Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 44(2): 353-9, 1991.
Article in English | MEDLINE | ID: mdl-1658680

ABSTRACT

Free radicals have been implicated in a number of pathological conditions. To evaluate the neurophysiological consequences of free radical exposure, slices of hippocampus isolated from guinea-pigs were exposed to hydrogen peroxide which reacts with tissue iron to generate hydroxyl free radicals. Long-term potentiation, a sustained increase in synaptic responses, was elicited in field CA1 by high frequency stimulation of an afferent pathway. We found that 0.002% peroxide did not directly affect the responses evoked by stimulation of the afferent pathway but did prevent maintenance of long-term potentiation. Short-term potentiation and paired-pulse facilitation were not affected by peroxide treatment. Peroxide was less effective if removed following high frequency stimulation and was ineffective if applied only after high frequency stimulation. Input/output analysis showed that the increase in synaptic efficacy was reduced with peroxide treatment. Changes in the enhanced ability of the synaptic potential to generate a spike were less apparent. These data show that the interference of free radicals with long-term potentiation may contribute to pathological deficits. It is possible that intracellular calcium regulation is disrupted by peroxide treatment. A number of second messenger systems involved with long-term potentiation are potential targets for free radical attack.


Subject(s)
Hippocampus/physiology , Hydroxides/pharmacology , Synapses/physiology , Animals , Dose-Response Relationship, Drug , Electric Stimulation/methods , Free Radicals , Guinea Pigs , Hippocampus/drug effects , Hydroxyl Radical , In Vitro Techniques , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Osmolar Concentration , Peroxides/pharmacology , Synapses/drug effects , Time Factors
2.
J Neurosci Methods ; 28(1-2): 51-7, 1989 May.
Article in English | MEDLINE | ID: mdl-2786117

ABSTRACT

Since MPTP and its metabolite MPP+ produce nigrostriatal lesions and symptoms similar to Parkinson's disease, recent studies have aimed toward defining their selectivity and neurotoxic mechanisms. In mitochondria in vitro, MPP+ blocked electron transport and decreased oxygen consumption. However, these effects were not selective to striatal mitochondria or even to mitochondria from brain, they required concentrations of MPP+ much greater than those found in vivo, and physiological actions could not be related to intramitochondrial changes. Lower doses of MPP+ did produce highly selective degeneration of dopaminergic (DA) neurons in cell cultures. We report here that MPP+ provoked large (80%) oxidations of cytochrome b and large K+o increments (approximately 30 mM) in rat striatal slices. These effects were slowed by mazindol, which inhibits DA uptake, and were markedly attenuated in rat hippocampal slices which have little DA input. Since DA terminals comprise only 2-4% of the striatal mass, the large MPP+-induced changes suggest that while MPP+ neurotoxicity in brain requires the presence of functioning DA terminals, effects are not confined to these terminals. Such studies illustrate the complexity of MPP+ neurotoxicity and demonstrate the importance of investigations in models such as brain slices with an extracellular space and intracellular relationships as in intact brain.


Subject(s)
Corpus Striatum/physiopathology , Cytochromes/metabolism , Hippocampus/physiopathology , Pyridinium Compounds/toxicity , 1-Methyl-4-phenylpyridinium , Animals , Corpus Striatum/drug effects , Hippocampus/drug effects , In Vitro Techniques , Male , Microtomy , Oxidation-Reduction , Rats , Rats, Inbred Strains
3.
Brain Res ; 475(2): 283-90, 1988 Dec 20.
Article in English | MEDLINE | ID: mdl-3265070

ABSTRACT

MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) produces symptoms similar to idiopathic Parkinson's disease in primates. A metabolite of MPTP, MPP+ (1-methyl-4-phenylpyridinium), is actively accumulated by dopaminergic (DA) terminals and selectively destroys nigrostriatal DA neurons. The mechanism of this effect remains unknown but reports that MPP+ inhibits electron transport in isolated mitochondria and increases oxidation of cytochrome b in striatal slices suggest that depression of ATP production is involved. To relate metabolic effects of MPP+ with tissue electrophysiology, extracellular potassium ion activity [K+]o was measured by microelectrodes simultaneous to optical monitoring of reduction/oxidation (redox) activity of cytochrome b during superfusion of MPP+ onto rat striatal and hippocampal slices. MPP+ increased oxidation of cytochrome b and increased [K+]o in slices of striatum. These increases were greater than expected from a selective effect of MPP+ on DA terminals which likely comprise no more than 3% of the total striatal mass. These effects of MPP+ were slowed by a dopamine uptake inhibitor (mazindol) and did not occur in hippocampal slices. These findings indicate that MPP+ influences ion transport as well as metabolic activity and that these actions require the presence of functioning DA terminals. However, the large amplitudes of the MPP+-induced changes suggest that consequences of MPP+-neurotoxicity are not ultimately confined to DA terminals. Two hypothesis are proposed: that energy failure in DA terminals results in leakage of neurotoxic substances or metabolites altering membrane conductance properties of adjacent cells and thereby placing additional demand upon ion transport pumps and mitochondrial oxidative phosphorylation; or that there is secondary uptake of MPP+ leading to mitochondrial inhibition in cells neighboring DA terminals.


Subject(s)
Corpus Striatum/metabolism , Dopamine/physiology , Neurotoxins/pharmacology , Potassium/metabolism , Pyridinium Compounds/pharmacology , 1-Methyl-4-phenylpyridinium , Animals , Corpus Striatum/drug effects , Cytochrome b Group/metabolism , Dopamine/metabolism , Electrophysiology/methods , Male , Mazindol/pharmacology , Oxidation-Reduction , Oxygen Consumption , Pyridinium Compounds/toxicity , Rats , Rats, Inbred Strains
4.
Brain Res ; 443(1-2): 183-9, 1988 Mar 08.
Article in English | MEDLINE | ID: mdl-3258785

ABSTRACT

Effects of 1-methyl-4-phenylpyridinium, (the active metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), on reduction/oxidation activity of mitochondrial cytochromes were studied in rat striatal slices using scanning spectrophotometry. The objective was to test the hypothesis that the neurotoxin alters electron transport in the mitochondrial respiratory chain. Incubation of rat striatal slices with MPP+ (1 microM) produced a time-dependent oxidation of Cytochrome-b in a manner consistent with the concept of a block in electron transport in the intramitochondrial respiratory chain between nicotinamide adenine dinucleotide (NAD) and Cytochrome-b. This effect of MPP+ was decreased by co-incubation with a potent dopamine uptake inhibitor (mazindol), or when studied in a tissue with low dopaminergic innervation (hippocampus). The amplitude of Cytochrome-b oxidation was greater than that expected from a selective effect of MPP+ on dopaminergic neurons suggesting that neighboring cells are influenced secondary to the MPP+ effect on dopaminergic terminals.


Subject(s)
Corpus Striatum/metabolism , Cytochrome b Group/metabolism , Neurotoxins/pharmacology , Pyridinium Compounds/pharmacology , 1-Methyl-4-phenylpyridinium , Animals , Corpus Striatum/drug effects , Hippocampus/drug effects , Hippocampus/metabolism , In Vitro Techniques , Kinetics , Male , Mazindol/pharmacology , Oxidation-Reduction , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...